Join the Chronic Obstructive Pulmonary Disease group to help and get support from people like you.
Chronic Obstructive Pulmonary Disease News (Page 5)
Related terms: Chronic Obstructive Pulmonary Disease, Acute, Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, COPD, Acute, COPD, Maintenance, Emphysema, Chronic Obstructive Pulmonary Disease, Maintenance, COPD
FDA Approves Breo Ellipta to Treat Chronic Obstructive Pulmonary Disease (COPD)
May 10, 2013 – The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term, once-daily, maintenance treatment of...
Horizon Pharma Announces FDA Approval of Rayos (prednisone) Delayed-Release Tablets for Rheumatoid Arthritis and Multiple Additional Indications
DEERFIELD, Ill., July 26, 2012 /PRNewswire/ – Horizon Pharma, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Rayos (prednisone) delayed-release tablets (1 mg, 2...
FDA Approves Tudorza Pressair to Treat Chronic Obstructive Pulmonary Disease
July 23, 2012 – The U.S. Food and Drug Administration today approved Tudorza Pressair (aclidinium bromide) for the long-term maintenance treatment of bronchospasm (narrowing of the airways in the...
FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
RIDGEFIELD, Conn., Oct. 7, 2011 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Combivent Respimat, a new,...
FDA Approves Arcapta Neohaler to treat Chronic Obstructive Pulmonary Disease
The U.S. Food and Drug Administration today approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in...
FDA Approves Daliresp to Treat Chronic Obstructive Pulmonary Disease
SILVER SPRING, Md., March 1, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration approved Daliresp (roflumilast), a pill taken daily to decrease the frequency of flare-ups...
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
RIDGEFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--Dec 17, 2009 - Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved...
FDA Medwatch Alert: Unapproved Compounded Inhalation Drugs
[Posted 08/10/2006] The FDA notified consumers and healthcare professionals that RoTech Healthcare, Inc., CCS Medical, and Reliant Pharmacy Services are manufacturing and distributing unapproved...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
prednisone, albuterol, Symbicort, Trelegy Ellipta, montelukast, Anoro Ellipta